Lung Cancer Faculty
Our virtual Center of Excellence in the treatment of Lung Cancer leverages technology to create a collaborative and comprehensive way to improve patient care. This unique center has the key advantages of a real world academic center as well as the features and enhancements that only PracticeUpdate and Elsevier can provide to foster an expert-led team approach that helps you stay ahead.
Editorial Contributor
Recently Updated
- Clonal KEAP1 Mutations With Loss of Heterozygosity Associated With Reduced Immunotherapy Efficacy and Low Immune Cell Infiltration in Patients With Lung Adenocarcinoma
- Emerging Strategies for the Treatment of Patients With SCLC
- Atezolizumab Plus Bevacizumab as First-Line Treatment for Patients With Metastatic Nonsquamous NSCLC With High Tumor Mutation Burden
- Pembrolizumab Plus Chemotherapy in Patients With Advanced NSCLC Who Progressed on PD-1/PD-L1 Inhibitors
- Association Between Clonal Hematopoiesis and Risk of Incident Lung Cancer